# McMaster Children's Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/mcmaster-children-s-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 67.7 |
| Citations | 202,727 |
| City | Hamilton |
| Country | CA |
| Description | McMaster Children's Hospital is a research organisation in Hamilton, CA. OpenAlex records 3,215 works and 202,727 citations for it. 613 researchers list it as their most recent affiliation. |
| Homepage | http://www.mcmasterchildrenshospital.ca/ |
| OpenAlex ID | https://openalex.org/I2801880889 |
| Region | Ontario |
| Researchers | 613 |
| ROR ID | https://ror.org/03cegwq60 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q6802304 |
| Works | 3,215 |

## University papers

- [Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS](https://scholariq.org/papers/expanded-ggggcc-hexanucleotide-repeat-in-noncoding-region-of-c9orf72-causes/)
- [Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS](https://scholariq.org/papers/mutations-in-prion-like-domains-in-hnrnpa2b1-and-hnrnpa1-cause-multisystem/)
- [Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial](https://scholariq.org/papers/efficacy-of-minocycline-in-patients-with-amyotrophic-lateral-sclerosis-a-phase/)
- [American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism](https://scholariq.org/papers/american-society-of-hematology-2018-guidelines-for-management-of-venous-3/)
- [Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial](https://scholariq.org/papers/rivaroxaban-compared-with-standard-anticoagulants-for-the-treatment-of-acute/)
- [NEK1 variants confer susceptibility to amyotrophic lateral sclerosis](https://scholariq.org/papers/nek1-variants-confer-susceptibility-to-amyotrophic-lateral-sclerosis/)
- [Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i> -associated amyotrophic lateral sclerosis](https://scholariq.org/papers/poly-gp-proteins-are-a-useful-pharmacodynamic-marker-for-i-c9orf72-i-associated/)

## University top topics

Showing 8 of 25.

- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [Pediatric Pain Management Techniques](https://scholariq.org/topics/pediatric-pain-management-techniques/)
- [Infant Development and Preterm Care](https://scholariq.org/topics/infant-development-and-preterm-care/)
- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)
- [Adolescent and Pediatric Healthcare](https://scholariq.org/topics/adolescent-and-pediatric-healthcare/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.